Abstract -The aim of the present study was to develop and evaluate curcumin nanoparticles using low viscous chitosan and tripolyphosphat at various concentrations for anticancer therapy. Curcumin nanoparticles prepared by ionic gelation method using chitosan and TPP at various concentrations. Curcumin nanoparticles were then characterized for their particle size, zeta potential, morphology and entrapment efficiency. Furthermore, curcumin-chitosan nanoparticles were evaluated for their stability in artificial gastric fluid (AGF) and artificial intestinal fluid (AIF) by quantitating the release of curcumin from the nanoparticles, cellular uptake of curcumin nanoparticles investigated using fluorescence microscopy and cytotoxic effect on HeLa cell lines and normal cell lines (Vero) by calculating the level of LC 50 which was based on the percentage of the cell death following the 24 hours incubation with the nanoparticles. The mean particle size of curcumin nanoparticles were 100 to 400 nm, zeta potential were (-) 3 to (+) 30 mV entrapment efficiency of curcumin in nanoparticles were 73,63 to 85,71% with the observed shapes of nanoparticles was spherical. Curcumin nanoparticles were stable in artificial gastric fluid and artificial intestinal fluid. Curcumin nanoparticles were more cytotoxic to HeLa cell line and there was a statistically significant difference (p value 0.05) in potensial cytotoxicity in HeLa cell lines in comparison to vero cell lines, cellular uptake studies of curcumin nanoparticles showed that nanoparticles were able to intenalize the HeLa cell lines.
I. INTRODUCTION
Curcumin a polyphenolic compound which is found in turmeric of Curcuma longa has wide range of pharmacological activities that include anticancer properties [1] . Curcumin has limitation for anticancer therapy because of its poor solubility in aqueous solution and its poor bioavailability in systemic circulation. Polymer-based nanoparticles using chitosan is one of the method which has been tried to enhance curcumin solubility and bioavailability [2] .
Chitosan, a natural polymer can be derived from exoskeleton of shellfish and insect. Chitosan, (1,4)-2-amino-2-deoksi-β-D-glukan the deacetylated derivative of chitin, is biodegradable, biocompatible, non toxic, abundant, renewable polymer has the unique characteristic because it provides 1* Suryani, Departement of Pharmacy, Faculty of Pharmacy, Universitas Halu Oleo, Indonesia, Email: Soerysuer@yahoo.com 2 Ronny Martien & Hilda Ismail, Department of Pharmacy, Faculty of Pharmacy, Gadjah Mada University, Indonesia higher affinity for negatively charged biological membranes and site-specific targeting in vivo [4] .
The ionotropic gelation method is commonly used to prepare chitosan nanoparticles [9] . The mechanism of chitosan nanoparticle formation is based on electrostatic interaction between amine group of chitosan and negatively charge group of polyanion such as tripolyphosphat. This technique is a simple preparation method in the aqueous environment. The size and surface properties of particles can be modified by varying the ratio of polymer and polyanion [5] .
In our present works, we prepared nanoparticles curcumin by ionic gelation method using low viscous chitosan and tripolyphosphat at various concentrations, Curcumin nanoparticles were then characterized for their particle size, zeta potential, morphology and entrapment efficiency. Furthermore, curcumin nanoparticles were evaluated for their stability in artificial gastric fluid (AGF) and artificial intestinal fluid (AIF), cytotoxic effect and cellular uptake on HeLa cell lines.
II. MATERIALS AND METHOD

A. Materials
Low viscous chitosan and sodium TPP purchased from Sigma-Aldrich, curcumin as gift sample from Curcumin Research Centre UGM, Yogyakarta, phosphate buffer saline (PBS), MTT reagent purchased from Merck, USA, HeLa and Vero cell line was obtained from Parasitology Laboratory, Faculty of Medicine, UGM, Yogyakarta, Dulbecco's Modified Eagle Medium (DMEM) 10% (v/v), Fetal Bovine Serum (FBS) 10% (v/v), penisilin-streptomisin 1% (v/v), tripsin-EDTA 0,25% purchased from Gibco, USA, stopper reagent sodium dodecyl sulfate purchased from Merck-Schuchardt. All chemicals and solvent used in this study were of analytical grade.
B. Preparation of Nanoparticles
Three different chitosan concentrations (0.02, 0.04 and 0.06%) were made in acetate buffer solution pH 4, curcumin was dissolved in 96% ethanol yielding concentration of 0.01, 0.02, 0.03, and 0.04%. TPP solution (0,01, 0.02, and 0.03%) were prepared using distilled water. Curcumin nanoparticles were prepared using an ionic gelation method. The curcumin solution (0,5 mL) was added to the chitosan solution (0,5 mL) and then homogenized using vortex for 20 seconds. To the above prepared mixture, 0,5 mL of TPP solution was added and re-homogenized using vortex for 20 seconds. dispersions of nanoparticle were left at room temperature for 7 days and observed amount of unentrapped curcumin to determine the optimum dispersion for further treatment. The optimum dispersion were scaled up to 400 mL and ethanol was removed using rotary evaporator. Finally, curcumin nanoparticles were freezed dry at -40 o C.
C. Entrapment Efficiency
Freezed dry nanoparticles (5,0 mg) were crushed and dispersed in 5,0 mL distilled water, 5,0 mL of ethyl acetate then added. The mixture was shaken and ethyl acetate phase being separated. Free curcumin content in ethyl acetate phase was determined using an UV-Vis spectrophotometer at 419 nm. The percentage drug entrapment efficiency was calculated using equation (1) .
D. Particles size and zeta potential
The particles size and zeta potential were determined by using particle size analyzer. The samples were analyzed in scattering angle of 165 and the process parameters were set as: temperature of 25 º C, refractive index of 1,3328 and viscosity of 0,8878. Briefly, in each determination, 5 mg of nanoparticles were dissolved in 5,0 mL of distilled water, 2 drops of nanoparticles solution ware added to 5 mL of distilled water, 3 mL of the mixture was taken and then analysed.
E. Morphology
Morphological characteristics of the nanoparticles were examined using Transmission Electron Microscope (TEM). A drop of nanoparticles was placed over carbon coated (JOEL JEC-560, Japan) and allowed to air dry for 24 hours at room temperature. Once the nanoparticle samples were dried, they coated again with carbon as mentioned above before loaded in the miscroscope. The images were visulized at 120 kV and 15000 magnification.
F. Stability assay
This experiment was preformed in order to predict the stability of the nanoparticles in artificial gastric fluid and artificial intestintinal fluid. The freezed dry nanoparticles (5,0 mg) were dissolved in artificial gastric fluid (5 mL). The solutions were shaken using Orbital Incubator Shaker (Environ Shake) at 39°C and 100 rpm. The experiment was performed in triplicates. At particular time intervals, ethyl acetate then added to these solutions. The mixture was shaken and ethyl acetate phase being separated. Free curcumin content in ethyl acetate phase was determined using an UV-Vis spectrophotometer at 419 nm to estimate the amount of curcumin released from the nanoparticles. The stability of the nanoparticles in artificial intestinal fluid was determined through the same method as mentioned above.
G. Cytotoxicity Assay
Cytotoxicity of the nanoparticles was conducted in 96 well flat bottom ELISA plates using MTT assay . In this study, we compared the cytotoxicity effects of nanoparticles in HeLa cells and Vero cells using t-test independent sample test (p 0,05). Nanoparticles were tested on a 2-fold dilution series of concentrations in water, from 100 μg/mL to 1,5625 μg/mL. Each well received 100 µL of cell suspension and 100 μL of the appropriate dilution of samples. Plates were then incubated in a 37°C humidified incubator in 5% C0 2 for 24 h. Following incubation the medium was removed and the cells were resuspended in fresh DMEM medium, 10 µ1 of 5 mg/mL MTT (Sigma) were added, and then further incubated for 4 h. The reaction was stopped by the addition of 100 µ1 stopper reagent sodium dodecyl sulfate and the absorbance was measured in an Elisa plate reader at λ 595 nm. The absorbance values were directly proportional to the number of death cells. Untreated cells were used as control (0% cytotoxicity). Mean percent cytotoxicity was then calculated following treatment relative to controls. There were 3 replicate wells for each treatment.
H. Cellular Uptake Study
Cellular uptake of nanoparticles in HeLa cells were observed using fluorescent microscope (zeiss). Briefly, HeLa cells (5x10 4 sel/plate) were placed on six plates with cover slip coated at the bottom of the well and incubated in a 37°C humidified incubator in 5% C0 2 over night until starvation. Next day, medium was removed and the cells were resuspended in fresh DMEM medium. The cells were incubated for 4 hours with a fixed concentration (10 μg/100µL) of nanoparticles. After incubation, methanol was added then discarded immediately. Cover slip then loaded in the miscroscope.
III. RESULT AND DISCUSSION
A. Nanoparticles Preparation
Pre preparation on a mini scale was conducted to determine a stable preparation of curcumin nanoparticles. The observations were done for 7 days and the preparation at ratio of curcumin:chitosan:TPP 0,01; 0,02; 0,01 (A1), 0,01; 0,04 ; 0,01 (A2), 0,01 ; 0,02; 0,02 (B1) dan 0,01; 0,04; 0,02 (B2) appeared to be stable as the stability data of nanoparticles showed less of white and yellow precipitates were formed during the storage at room temperature. The result showed, increasing concentration of TPP leads to an increase number of precipitate were formed. Probably it caused by TPP not only as a cross linker in a particle but also linked particle with another resulting in aggregation. In this study chitosan nanoparticles based on ionic interaction between curcumin and chitosan. From the literature it can be derived that in acidic solution, the -NH 2 group of chitosan molecule is protonized and interacts with the oxygen atom that negatively charge in curcumin and cause a spontaneous forming of particles (Figure 1 ), which are finally improved by adding tripolyphosphat (figure 2). 
B. Entrapment Efficiency
The entrapment efficiency of curcumin in nanoparticles (A1, A2, B1 and B2) were 84,48 73,63, 80,71 and 85,71%, respectively. The curcumin entrapment in nanoparticles were in satisfaction as they were greater than 70 %.
Fig. 3 Entrapment efficiency of nanoparticles
C. Particles size and zeta potential
The average particle size and size distribution of curcumin nanoparticles were measured using particle size analyzer . The particle size of all nanoparticles (A1, A2, B1 and B2) were 113,9±28,8, 323,6±144,5, 194,6±49,9 and 341,2±168,1 nm, respectively. The results showed that increasing chitosan concentrations as well as increasing tripolyphosphat concentrations will lead to increasing particle diameters [11, 12] . The uniformity or dispersity homogeneity of the nanoparticles were determined by measuring the polydispersity index (PI). PI values close to zero indicate a homogeneous dispersion while those greater than 0,3 indicate high heterogeneity [13] .
The PI values of the prepared nanoparticles, A1, A2, B1 and B2 were 0,694, 0,535, 0,956 and 0,677 respectively. The high heterogenity of nanoparticles preparation was also demonstrated by standard deviation values which resulted in nanoparticle size measurments. The zeta potensial of nanoparticles were determined using a zeta potensial analyzer. The zeta potensials of nanoparticles (A1, A2, B1 and B2) were (-)2,57, (+)27,55, (+)19,94 and (+)21, 19, repectively. The average particle sizes, polydispersity index (PI) and zeta potential values are shown in Table 1 . 
D. Morphology
According to the TEM images of prepared nanoparticles with composition of curcumin:chitosan:TPP 0,01:0,04:0,01, the observed shapes of nanoparticle was spherical. 
E. Stability assay
The stability of curcumin nanoparticles in artificial gastric fluid and artificial intestintinal fluid was studied. The release of curcumin from the nanoparticles was dependent on pH values of the medium. In artificial gastric fluid, the curcumin nanoparticle get swelled because of chitosan was soluble in acidic medium, chitosan then degradated leading to the release of curcumin from the nanoparticles. When nanoparticles at higher pH (pH 7) of artificial intestinal fluid, NH 3 + of chitosan get deprotonated and changing to NH 2 , carbonyl group of curcumin that negatively charge no longer able to interact with NH 2 group of chitosan and leading to the release of curcumin from nanoparticles. 
F. Cytoxicity assay
In this study, a cytotoxicity assays of curcumin nanoparticles ware assessed on cancer cell lines (HeLa) and normal cell lines (Vero). The results indicated that curcumin nanoparticles had an inhibition effect on HeLa and vero cell lines. When the concentration of curcumin nanoparticles was reduced by serial dilution, the effects on HeLa and vero cell-lines were also decreased. The calculated LC50 indicated that the curcumin nanoparticles was more cytotoxic to HeLa cell lines compared to vero cell lines ( Figure 7 ). However, there was a statistically significant difference in potensial cytotoxicity in HeLa cell lines in comparison to vero cell lines (p value 0,05). 
G. Cellular Uptake
Cellular uptake studies of nanoparticles by cancerous cells (HeLa) were done using fluorescence microscope (Figure 8 ). After internalization of nanoparticles into the cells, chitosan was than degraded by lysozim and leading to the release of curcumin from the nanoparticles. Curcumin demonstrated fluorescence activity and observed using fluorescence miscroscopy.
The internalization mechanism of nanoparticles into the cell through an endocytosis process. It has shown that positively charged nanoparticle internalize rapidly into the HeLa cell via the clathrin-mediated pathway [14] .
It has been reported that intracellular uptake was dependent on the particle size and shape. The smaller particles have a relatively higher intracellular uptake compared with large particle. Frenkel et al., (2006) reported that intracellular uptake was dependent on the surface charge of nanoparticles. Positively charged nanoparticles reveal a higher rate of internalization than negatively charged nanoparticles on HeLa cells. The stability of nanoparticles outside of the cells was also play important role in delivering cucumin into the cells. A stable nanoparticles outside the cells may deliver higher curcumin into the cells.
H. Cellular Uptake
The internalization mechanism of nanoparticles into the cell through an endocytosis process. It has shown that positively charged nanoparticle internalize rapidly into the HeLa cell via the clathrin-mediated pathway [14] . It has been reported that intracellular uptake was dependent on the particle size and shape. The smaller particles have a relatively higher intracellular uptake compared with large particle. Frenkel et al., (2006) reported that intracellular uptake was dependent on the surface charge of nanoparticles. Positively charged nanoparticles reveal a higher rate of internalization than negatively charged nanoparticles on HeLa cells. The stability of nanoparticles outside of the cells was also play important role in delivering cucumin into the cells. A stable nanoparticles outside the cells may deliver higher curcumin into the cells.
IV. CONCLUSION
Curcumin nanoparticles can be developed using low viscous chitosan and TPP. The mean particle size were 100 to 400 nm, zeta potensial were (-)3to (+)30 mV, entrapment efficiency were 70 to 90% with the observed shapes of nanoparticle was spherical. Nanoparticles were stable in artificial gastric fluid andrtificial intestinal fluid. Nanoparticles were more cytotoxic to HeLa then Vero cell lines. However, there was a statistically significant difference in potensial cytotoxicity in HeLa cell line in comparison to vero cell lines (p value 0,05). Cellular uptake studies of curcumin nanoparticles using fluoroscence microscopy showed that nanoparticles were able to intenalize the HeLa cell lines. Ovearall finding suggested that curcumin nanoparticles could be a promising preparation for anticancer therapy. 
